Analyst consensus rating

Kura Oncology Analyst Rating: Strong Buy

Direct answer

Kura Oncology's consensus rating is Strong Buy.

13 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $32.00.
Forecast evidence checked November 21, 2026.

Get free Kura Oncology email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$6.91
Average price target
$32.00
High price target
$76.00
Low price target
$15.00
Low target gap
+117.1%
Target upside
+363.1%
High target gap
+999.9%
Target range width
882.8%
Consensus rating
Strong Buy
Analysts
13
Evidence date
November 21, 2026
Valid through
November 28, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Kura Oncology?

Kura Oncology has a verified Strong Buy consensus. The same dataset has an average price target of $32.00.

How far are Kura Oncology's low and high targets from the recorded price?

The low target implies +117.1%, while the high target implies +999.9%.

How many analysts are included in Kura Oncology's consensus?

The verified consensus includes 13 analysts.

How is Kura Oncology's target upside or downside calculated?

The average target of $32.00 is divided by the recorded price of $6.91, then one is subtracted to produce +363.1%. This does not guarantee a future return.

When was Kura Oncology's analyst forecast verified?

The data was verified on 2026-11-21. The dataset is valid through 2026-11-28.